IGM Biosciences, Inc. (IGMS) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 8 Buy, 10 Hold.
The consensus price target is $1.75 (low: $1.50, high: $2.00), representing an upside of 37.8% from the current price $1.27.
IGMS Stock — 12-Month Price Forecast
$1.75
▲ +37.80% Upside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for IGM Biosciences, Inc., the average price target is $1.75, with a high forecast of $2.00, and a low forecast of $1.50.
The average price target represents a +37.80% change from the last price of $1.27.
Highest Price Target
$2.00
Average Price Target
$1.75
Lowest Price Target
$1.50
IGMS Analyst Ratings
Hold
Based on 18 analysts giving stock ratings to IGM Biosciences, Inc. in the past 3 months
